Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention.
Journal of the American College of Cardiology.
Times cited: 23
Evaluation of a new heparin agent in percutaneous coronary intervention: Results of the Phase 2 evaluation of M118 in pErcutaNeous coronary intervention (EMINENCE) trial.
Times cited: 18